ccinfoadmin Publication date: September 2026 Source: Practical Laboratory Medicine, Volume 51 Author(s): Jordi Tortosa-Carreres, Nahúm Martí-Montoro, Miguel Rodríguez-Manotas, Begoña Laiz-Marro
Publication date: October 2026 Source: Clinical Biochemistry, Volume 145 Author(s): Natalia García-Sancha, Juan Valencia-Ramos, Simón Gundín-Menéndez, María Martín-Palencia, María Miranda-Vega, Sara Calvo-Simal, Juan Arnáez
Publication date: 15 February 2027 Source: Clinica Chimica Acta, Volume 593 Author(s): Jingzhen Li, Qianqian Zhang, Zhengyue Chen, Yingyin Qiu, Yuanping Liu
Publication date: 15 February 2027 Source: Clinica Chimica Acta, Volume 593 Author(s): Bo Ye, Jiong Zhang, Wenbo Zheng, Danzhou Tao, Zhongfu Zhang, Yushuai Ma, Taiqiang Zhao
Publication date: 15 February 2027 Source: Clinica Chimica Acta, Volume 593 Author(s): E. Grifnée, E. Cavalier, C. Le Goff
Clin Chem. 2026 Jul 29:hvag074. doi: 10.1093/clinchem/hvag074. Online ahead of print. ABSTRACT BACKGROUND: Next-generation sequencing (NGS), also known as massively parallel sequencing, has become an essential tool across many areas of the life sciences, yet its application to low-frequency variant detection remains constrained by intrinsic error rates and the high cost of ultra-deep sequencing. To … Read more
Publication date: 15 February 2027 Source: Clinica Chimica Acta, Volume 593 Author(s): Lei Shi, Zhuonan Wang, Jie Zhang, Ping Zheng, Lijun Bai
Publication date: 15 February 2027 Source: Clinica Chimica Acta, Volume 593 Author(s): Yoav Uchitel, Dirk Roggenbuck, Haim Leibovitzh, Nathaniel Aviv Cohen, Rony Izhar, Lior Lobel, Nitsan Maharshak, Lael Werner
Publication date: 15 February 2027 Source: Clinica Chimica Acta, Volume 593 Author(s): Jordi Tortosa-Carreres, Nahúm Martí-Montoro, Jonnathan Andrés Acevedo-Galvis, Cristel Pascual-Escrivà, Ricardo Alonso-Díaz, Óscar Fuster-Lluch, Laura Sahuquillo-Frias, Begoña Laiz-Marro
Clin Chem Lab Med. 2026 Jul 30. doi: 10.1515/cclm-2026-0536. Online ahead of print. ABSTRACT Population screening for type 1 diabetes (T1D) using pancreatic islet autoantibodies is increasingly recognized as a promising strategy to reduce diabetic ketoacidosis and identify individuals during the presymptomatic stages of the disease. In Italy, Law 130/2023 and the implementing decree of … Read more
